HeartSciences Inc. Form 8-K Summary
Business Context and Reporting Period
HeartSciences Inc. (HSCS), a Texas corporation, filed this Current Report on Form 8-K on December 16, 2025. The report discloses a corporate governance action taken by the Board of Directors on December 15, 2025.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a disclosure of a material definitive agreement and does not report on the company's financial performance.
Material Changes
The material change disclosed is the Board's approval of a form of Indemnification Agreement. This agreement is to be entered into with each director and executive officer. Key provisions include:
- Indemnification and advancement of expenses to the fullest extent permitted under Texas law and the Company's Certificate of Formation.
- Continued coverage under the Company's directors' and officers' insurance policies.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies related to operations or market conditions. The primary focus is the legal protection afforded to the company's leadership.
Key Facts for Investor Verification
- Verify the specific terms of the Indemnification Agreement in Exhibit 10.1 attached to the filing.
- Confirm the impact of this agreement on the company's directors' and officers' insurance coverage.
- Note that this filing does not update the company's financial status or operational outlook.